HBOT & Tissue Recovery — What the Research Shows · Oceanside, CA
TISSUE RECOVERY
IS AN OXYGEN
PROBLEM.
Whether you're healing from surgery, managing a chronic wound, or recovering from a soft tissue injury, the speed and quality of healing depends on oxygen availability at the cellular level. HBOT is one of the most researched tools for supporting tissue repair — with FDA clearance for specific wound applications and an expanding evidence base. This page explores what the science currently shows.
This page is educational and informational. It does not claim that HBOT treats, cures, or prevents any wound or tissue condition. HBOT has FDA clearance for specific wound applications but is not universally approved. Please work with your physician for guidance.
What the Research Shows
800%
Increase in circulating stem cells — primary repair cells — University of Pennsylvania1
Sig.
Improvement in wound healing outcomes across multiple controlled studies — Frontiers in Physiology, 20182
#1
Rated PT Clinic — North County 2025
The Biology of Tissue Healing
EVERY STAGE OF HEALING REQUIRES OXYGEN — AND MOST CHRONIC WOUNDS ARE HYPOXIC.
Tissue repair is a complex, oxygen-dependent biological process. Every stage of healing — from the initial inflammatory response through cell proliferation to final tissue remodeling — requires adequate oxygen delivery to the repair site. When oxygen is compromised, the process slows or stalls entirely.
This is why wounds fail to heal, why diabetic tissue complications develop, and why some injuries recover poorly despite adequate treatment. The common factor is hypoxia — inadequate oxygen at the tissue level. HBOT directly addresses this by delivering oxygen at concentrations far exceeding what normal breathing achieves, reaching tissue that compromised circulation cannot adequately supply.
The Four Stages of Healing — All Oxygen-Dependent
Inflammatory phase — white blood cells need oxygen to fight bacteria and clear debris
Proliferative phase — fibroblasts require oxygen to produce collagen for new tissue
Remodeling phase — collagen reorganization and tissue strengthening are oxygen-dependent
Angiogenesis — formation of new blood vessels requires oxygen-rich conditions
"HBOT significantly accelerates wound healing by delivering oxygen concentrations that allow tissue repair processes to operate at full biological capacity."
— Frontiers in Physiology, wound healing review, 2018
The FDA-Cleared Evidence Base
HBOT IS ONE OF FEW WOUND TREATMENTS WITH FDA CLEARANCE — BASED ON DECADES OF DATA.
HBOT has FDA clearance for diabetic foot ulcers, chronic refractory osteomyelitis, radiation tissue injury, and compromised skin grafts — making it one of the few non-surgical wound treatments with this regulatory recognition. The clearance is based on decades of clinical data showing measurable improvements in wound healing outcomes.
Beyond these cleared applications, researchers are investigating HBOT for soft tissue injuries, post-surgical recovery, and sports injuries where tissue repair has stalled or is proceeding too slowly. The biological mechanisms are consistent across applications.
Established and Emerging Applications
Diabetic foot ulcers — FDA-cleared; strong RCT data; Medicare-covered for qualifying patients
Radiation tissue damage — FDA-cleared for radiation-induced injury
Compromised grafts and flaps — FDA-cleared; used in plastic and reconstructive surgery
Soft tissue injury recovery — emerging evidence in sports medicine and rehabilitation
Post-surgical healing — investigated for complex wound complications
WANT TO KNOW IF HBOT IS RIGHT FOR YOU?
The Research Angle
WHAT HBOT DOES
THAT RESEARCHERS
ARE INVESTIGATING
THAT RESEARCHERS
ARE INVESTIGATING
HBOT delivers 100% oxygen at increased atmospheric pressure. Researchers have identified six primary mechanisms through which this supports tissue repair — from stem cell mobilization to infection control.
🔬
Stem Cell Mobilization
Research at the University of Pennsylvania documented an 800% increase in circulating stem cells following HBOT — with confirmed migration to tissue injury sites. Stem cells are the body's primary repair cells, differentiating into fibroblasts, endothelial cells, and immune cells at wound sites. This mechanism dramatically amplifies the body's natural repair capacity in hypoxic areas healing poorly.
Angiogenesis — New Vessels
HBOT stimulates the formation of new capillaries in hypoxic tissue. Inadequate blood supply is one of the most common reasons wounds fail to heal — without vasculature delivering oxygen and removing waste, repair cells cannot function. By promoting angiogenesis in the wound bed, HBOT helps rebuild the vascular infrastructure that healing requires.
💧
Collagen Production
Fibroblasts — the cells responsible for collagen synthesis — require adequate oxygen to produce the structural proteins that form new tissue. In hypoxic wound environments, collagen production is severely impaired. HBOT's oxygen surge activates fibroblasts and accelerates collagen deposition, directly speeding the proliferative phase of healing and improving new tissue quality.
🔥
Infection Control
Wound infections are a primary cause of healing failure. HBOT directly impairs anaerobic bacterial survival while enhancing white blood cells' oxygen-dependent killing capacity — a dual antimicrobial effect. This can help control infection in wounds resistant to antibiotic treatment alone, particularly in diabetic and immunocompromised patients.
⚡
Mitochondrial Energy
Cellular repair is energy-intensive — every stage requires ATP production by mitochondria. In hypoxic wounds, repair cells are deprived of both the oxygen they need for energy production AND for repair functions. HBOT restores the oxygen supply that mitochondria need, allowing repair cells to operate at full metabolic capacity rather than the compromised state of chronic, slow-healing wounds.
📌
Reperfusion Injury Reduction
When blood flow is restored to ischemic tissue after surgery or injury, the sudden return of oxygen can paradoxically cause additional cellular damage — reperfusion injury. HBOT, appropriately administered, can reduce the inflammatory response associated with reperfusion and protect tissue that would otherwise be damaged during the healing process — relevant in post-surgical and vascular wound contexts.
Important Context
HBOT is one of the most evidence-supported modalities in wound care — particularly for diabetic and hypoxic wounds. The FDA clearances reflect decades of clinical data. It works best as part of a comprehensive wound care plan, not as a standalone intervention. For soft tissue injuries and post-surgical recovery outside the cleared indications, the evidence is promising but still developing in terms of high-powered RCTs.
The Clinical Evidence
WHAT THE STUDIES
HAVE FOUND
HAVE FOUND
Three of the most significant findings in HBOT and tissue recovery research — from stem cell mobilization to wound healing outcomes and FDA-recognized applications.
Mechanistic Research · American Journal of Physiology 2006
800% STEM CELL INCREASE — THE CELLULAR ENGINE OF TISSUE REPAIR
Dr. Stephen Thom's research at the University of Pennsylvania documented an 800% increase in circulating CD34+ stem cells following HBOT — and confirmed these cells migrated specifically to sites of tissue injury. This is the most important mechanistic finding in HBOT wound care: it demonstrates that HBOT actively mobilizes the body's repair system at scale, not just delivers oxygen passively.
For tissue recovery, the implications are direct. Stem cells arriving at wound sites differentiate into fibroblasts for collagen, endothelial cells for blood vessel formation, and immune cells for infection control. The 800% increase represents a dramatic amplification of the body's natural repair capacity in areas that are hypoxic and healing poorly.
Source: Thom et al., American Journal of Physiology, 2006. DOI: 10.1152/ajpheart.00306.2006
Review · Frontiers in Physiology 2018
SIGNIFICANT WOUND HEALING IMPROVEMENT ACROSS MULTIPLE CONTROLLED STUDIES
A comprehensive review in Frontiers in Physiology (2018) analyzed HBOT wound healing evidence across mechanisms and clinical applications, documenting significant improvements including accelerated closure rates, improved tissue oxygenation, enhanced collagen deposition, and reduced infection rates in hypoxic wound populations.
The review noted HBOT's effects are most pronounced in wounds where hypoxia is the primary limiting factor — diabetic wounds, radiation-damaged tissue, and ischemic wounds. This patient selection insight is important: HBOT works best where oxygen deficit is the bottleneck, which is often the case in the most difficult-to-heal wounds.
Source: Frontiers in Physiology, HBOT wound healing review, 2018.
FDA Clearance · Undersea and Hyperbaric Medicine Society
FDA CLEARANCE FOR DIABETIC WOUNDS, RADIATION INJURY, AND COMPROMISED TISSUE
HBOT has received FDA clearance for diabetic foot ulcers, radiation tissue injury, compromised skin grafts and flaps, and chronic refractory osteomyelitis. FDA clearance reflects decades of accumulated clinical evidence showing measurable improvements that standard care alone cannot achieve.
The diabetic foot ulcer data is particularly strong: multiple RCTs have documented significantly higher healing rates and lower amputation rates in patients receiving HBOT alongside standard wound care. This has made HBOT a Medicare-covered benefit for diabetic wounds meeting specific criteria — a regulatory recognition that reflects the strength of the evidence base.
Source: Undersea and Hyperbaric Medicine Society; FDA cleared indications for HBOT.
The Broader Research Context
HBOT is one of the few oxygen-based therapies with FDA clearance for specific clinical wound applications, and the wound care evidence base is among the strongest in HBOT medicine. The diabetic wound data is supported by multiple RCTs and has driven Medicare coverage. Research into soft tissue recovery, sports injuries, and post-surgical healing is expanding on this established foundation.
At Land and Sea PT, we offer HBOT as a wellness service for people dealing with challenging tissue recovery situations — including post-surgical healing, soft tissue injuries, and general recovery optimization. If you're navigating a healing challenge and want to understand what HBOT might add, we're glad to have that conversation.
WANT TO KNOW IF HBOT IS RIGHT FOR YOU?
Explore HBOT at Land and Sea PT
OTHER CONDITIONS
PEOPLE ARE EXPLORING WITH HBOT
PEOPLE ARE EXPLORING WITH HBOT
HBOT is being studied across a wide range of conditions. Explore what the research shows for other areas at Land and Sea PT in Oceanside.
🔥 Inflammation & Recovery
🫚
Long COVID
Fatigue, brain fog, breathlessness
🛡
Autoimmune
Immune dysregulation, inflammation
🔋
Chronic Fatigue
Low energy, brain fog, exhaustion
🔥
Chronic Inflammation
Systemic inflammatory response
⚡
Chronic Pain
Persistent pain, neuropathy, fibromyalgia
🌡
Fibromyalgia
Widespread pain, fatigue, sensitivity
🦠
Lyme Disease
Chronic symptoms, fatigue, joint pain
🩹
Tissue Recovery
Wound healing, diabetic tissue health
Current Page
🧬
Neuropathy
Nerve pain, tingling, numbness
🏥
Post-Surgical Recovery
Healing, swelling, tissue repair
🧠 Brain & Nervous System
Ready to Support Your Recovery?
LET'S HAVE A
CONVERSATION.
CONVERSATION.
If you're navigating a healing challenge — post-surgical, soft tissue injury, or chronic wound — we're here to walk you through what HBOT is, what the evidence shows, and whether it makes sense for your situation.
This page is educational only. HBOT has FDA clearance for specific wound applications but is not approved for all tissue recovery contexts. Results vary. Please work with your physician. HBOT at Land and Sea PT is offered as a wellness service.
📍 821 S Tremont St, Oceanside, CA
Serving Carlsbad · Vista · San Marcos · North County San Diego
Serving Carlsbad · Vista · San Marcos · North County San Diego
References
- Thom et al. "Stem cell mobilization by hyperbaric oxygen." American Journal of Physiology, 2006. DOI: 10.1152/ajpheart.00306.2006
- Frontiers in Physiology. Wound healing and hyperbaric oxygen review, 2018.
- Undersea and Hyperbaric Medicine Society. FDA-cleared indications for HBOT.